Target intelligence / Profile preview

A2ML1 antisense RNA 1 (A2ML1-AS1)

Target
A2ML1-AS1
Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

**A2ML1 antisense RNA 1 (A2ML1-AS1)** is a long non-coding RNA (lncRNA), identified by HGNC as A2ML1-AS1 (HGNC ID: 41022), located on chromosome 12. It is affiliated with the lncRNA class and currently has no known protein-coding function, enzymatic activity, or established role as a drug target; its biological function and mechanism are not well characterized. There is an association reported with otitis media, but no further functional or mechanistic details are currently available in the main gene and disease databases [5][7][8]. **Clarifications and assessment:** - This entry refers to an lncRNA gene, not a protein, enzyme, receptor, or other classic therapeutic target class [7][8]. - There is no current evidence of "A2ML1-AS1" being a direct molecular drug target or receptor. - There are no established interacting drugs, mechanisms of action, or biomarker usages related to this gene in the literature or gene annotation databases. - No safety or therapeutic development concerns specific to this gene are reported in the search results. **Summary**: "A2ML1 antisense RNA 1 (A2ML1-AS1)" is a long non-coding RNA with limited functional, mechanistic, or disease association information at this time, and is not a recognized therapeutic target or receptor [7][8].

02

Disease associations

Otitis media

Beyond the preview

Go deeper on A2ML1 antisense RNA 1 (A2ML1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A2ML1 antisense RNA 1 (A2ML1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call